Yan Leyfman: New Perspectives on Cancer Innovation With Dr. Shernan Holtan
Yan Leyfman/ X and Shernan Holtan/ X

Yan Leyfman: New Perspectives on Cancer Innovation With Dr. Shernan Holtan

Yan Leyfman, Medical Correspondent at OncLive, Freelance, Co-Founder and Executive Director of MedNews Week, shared on X:

“Advancing Cancer Innovation: Early Detection, Drug Discovery & Precision Medicine

Join MedNews Week for an insightful conversation with Dr. Shernan Holtan, Chief of Hematology and Cell Therapy at Allina Health and an internationally recognized leader in stem cell transplantation, cellular therapy, and GVHD research.

A pioneering physician-scientist whose contributions have helped shape modern transplantation practices and advance innovative cancer therapies, Dr. Holtan brings a unique perspective on translating scientific discoveries into meaningful improvements in patient care.

Explore the future of early cancer detection, drug discovery, and precision medicine, and the innovations transforming oncology.

Watch the full episode exclusively on OncoDaily TV.”

Yan Leyfman: New Perspectives on Cancer Innovation With Dr. Shernan Holtan

Other articles about precision oncology on OncoDaily.